Clinical Trials Logo

Clinical Trial Summary

The goals of the project are 1) to understand what are the neural mechanisms involved in the psychological treatment of obsessive-compulsive disorder (OCD) in children/adolescents and adults, 2) to assess potential differences in the neural mechanisms involved in the psychological treatment of OCD between children/adolescents and adults, and 3) to assess the effectiveness of intensive CBT for children/adolescents and adults with OCD.


Clinical Trial Description

Obsessive-compulsive disorder (OCD) is a frequent and disabling disorder. Cognitive-behavior therapy (CBT) is the best treatment option available for OCD, although it achieves optimum results in less than half of the patients. The investigators will investigate the main neural circuits that predict CBT outcome in OCD and the neural changes associated with CBT in two separate randomized controlled trials (RCTs), one in an adult sample and another in a pediatric sample. In this two RCTs, OCD participants will be randomized to either intensive CBT (20 sessions in 1 month) by a experienced clinician or a waiting-list control (WLC) and will be assessed (by a blind assessor) and scanned before and after CBT. Patients will be offered CBT if they have been randomized to the WLC. At baseline, the investigators will also compare OCD patients with a group of healthy controls (HC). Secondary goals of the project include 1) assessing potential differences between children/adolescents and adults in the neural mechanisms involved in CBT for OCD; 2) assess the effectiveness of intensive CBT for children/adolescents and adults. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04042038
Study type Interventional
Source Institut d'Investigació Biomèdica de Bellvitge
Contact Carles Soriano-Mas, PhD
Phone +34 260 65 75 00
Email csoriano@idibell.cat
Status Recruiting
Phase N/A
Start date May 1, 2019
Completion date September 1, 2023

See also
  Status Clinical Trial Phase
Recruiting NCT01949753 - Influence of Pregnenolone on Exposure Therapy in Obsessive-compulsive Disorder Phase 2
Completed NCT02267629 - Open Label Trial of Rapastinel (Formerly GLYX-13) in Individuals With Obsessive-Compulsive Disorder Phase 2
Completed NCT02867449 - Metacognitive Therapy for Obsessive-Compulsive Disorder N/A
Completed NCT01368510 - Intensive Cognitive-Behavioral Therapy For Obsessive-Compulsive Disorder N/A
Not yet recruiting NCT05422469 - OCD Biomarker Survey Employing sEEG and Stimulation: The OBSESS Trial N/A
Active, not recruiting NCT03300947 - Psilocybin for Treatment of Obsessive Compulsive Disorder Phase 1
Recruiting NCT02773082 - Reclaimâ„¢ Deep Brain Stimulation (DBS) Therapy for Obsessive-Compulsive Disorder (OCD) N/A
Not yet recruiting NCT06360991 - DBS for Treatment-resistant Obsessive-compulsive Disorder N/A
Completed NCT03605316 - Deep Electrical Neuromodulation in Obsessive-compulsive Disorder